Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists

Details Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists

1998-08-12

1999-12-21

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

544 96, 544 97, 544137, 546 22, 546209, 5462721, 548112, 548240, 548243, 548246, 514 89, 514 90, 514 92, 5142368, 514326, 514340, 514378, 514380, A61K 31535, A61K 3142, C07D26510, C07D26102

Patent

active

060049553

ABSTRACT:
##STR1## This invention relates generally to cyclic carbamates and hydroxylamines which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.

REFERENCES:
patent: 5187157 (1993-02-01), Kettner et al.
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5811441 (1998-09-01), Olson et al.
patent: 5849736 (1998-12-01), Wityak et al.
Laganis & Chenard, 1984, Tetrahedron Lett., vol. 25, No. 51, 5831-5834.
Phillips et al. 1991, Cell, 65, 359-362.
Remington's Pharmaceutical Sciences, 17.sup.th. Ed., Mack Publishing Co., 1985, 1418.
Oliver et al., J. Med. Chem. 1991, 34, 851-854.
Cava et al., J. Am. Chem. Soc., 1958, 80, 2257-2263.
Johnson and Livak, 1936, J. Am. Chem. Soc., 58, 299-303.
Rico et al., 1993, J. Org. Chem., 58, 7948-51.
Meier and Zeller, 1975, Angew. Chem. Int. Ed., 14, 32-43.
Greenlee et al., 1985, J. Med. Chem. 28, 434-442.
Waki, 1981, Synthesis, 266-268.
Corey and Schmidt, 1979, Tetrahedron Lett. 399-402.
Kim et al., 1993, Tetrahedron Lett. vol. 34, No. 48, 7677-7680.

Affiliated with

Also associated with

Rating

Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-505316